#bispecific — Thursday, June 25, 2026 (1 items)
| 0 | 💬 0 |
Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial.
(nature.com)
|
Nature Medicine 2026-06-25 | #myeloma #clinical trial #immunotherapy #bispecific #transplantation |